AST Products, Inc.

06/05/2025

Attending and exhibiting at the 2025 AECOS Europe Symposium from June 5th to 8th.

05/26/2025

Exciting News – Another Published Study on Asqelio™ EDOF IOL!
May 26, 2025

We’re thrilled to share some fantastic news! Our ninth peer-reviewed scientific paper on the Asqelio™ EDOF intraocular lens (IOL) has just been published in the Journal of Clinical Medicine (Vol. 14, pages 3717–3730, 2025). The full paper is now freely available online through the link below.

This latest study looked at how well the Asqelio™ EDOF lens performs in real-life patients who had cataract surgery or a similar vision correction procedure (refractive lensectomy). The lens is designed to help patients see clearly across different distances, especially intermediate and far distances, without the need for glasses.

In the study, 23 patients (46 eyes) received the Asqelio™ EDOF lens, and 17 patients (34 eyes) received a standard monofocal lens for comparison. The results were encouraging:

- 91% of eyes with the Asqelio™ lens achieved excellent accuracy in vision correction.

- Patients could see well at a distance, and also had good vision at arm’s length and near.

- Vision quality, contrast, and image clarity were similar to the monofocal lens group.

- Patients with the Asqelio™ lens experienced fewer visual distortions and reported high satisfaction.

- Importantly, there were no safety concerns or negative side effects reported.

What does this mean?
This study supports that the Asqelio™ EDOF lens is a strong option for patients who want more freedom from glasses and a broader range of clear vision after surgery—all with minimal side effects.

We’re deeply grateful to all the doctors, researchers, and hospital staff who made this study possible. Their dedication continues to inspire us to keep moving forward, staying true to our mission:
‘Making Happy Patients, One-by-One.’

https://doi.org/10.3390/jcm14113717

04/27/2025

3rd day (final) of our exhibition at the ASCRS (American Society of Cataract and Refractive Surgery) 2025 Annual Meeting.

Date: April 25th to 28th, 2025.
Venue: Los Angeles Convention Center, California.

Please visit us at booth #925.

04/26/2025

2nd day of our exhibition at the ASCRS (American Society of Cataract and Refractive Surgery) 2025 Annual Meeting.

Date: April 25th to 28th, 2025.
Venue: Los Angeles Convention Center, California.

Please visit us at booth #925.

04/25/2025

1st day of our exhibition at the ASCRS (American Society of Cataract and Refractive Surgery) 2025 Annual Meeting.

Date: April 25th to 28th, 2025.
Venue: Los Angeles Convention Center, California.

Please visit us at booth #925.

04/24/2025

We will be exhibiting at the 2025 ASCRS (American Society of Cataract and Refractive Surgery) Annual Meeting starting tomorrow.

Date: April 25th to 28th, 2025.
Venue: Los Angeles Convention Center, California.

Please visit us at booth #925.

02/26/2025

Today (February 26, 2025), we are very excited to receive the good news to announce another publication of the 9th peer-reviewed technical paper on our Asqelio™ EDOF IOL in the Frontiers in Medicine, Sec. Ophthalmology (2025, v12:1513803). The paper is now available as open access via the link below.

This study aims to evaluate refractive, visual, and patient-reported outcomes three months after bilateral implantation of a novel bi-aspheric, non-diffractive extended depth of focus (EDOF) intraocular lens (IOL) using Phase-Ring™ technology to achieve good vision across distances with reduced dysphotopsia.

The study concluded that Asqelio™ EDOF IOL offers an efficient design, providing good clinical outcomes for distance and intermediate vision, while some patients reach functional levels of near vision. Its non-diffractive design minimizes dysphotopsia and reduces light distortion compared to other presbyopia-correcting IOLs.

Many thanks to all team members, doctors, the hospital that had contributed and collaborated on this study. The result certainly has further convinced and encouraged us to progressively move forward and to ‘Making Happy Patients, One-by-One'.

This article is part of the Research Topic Enhancing Patient Outcomes After Cataract, Corneal and Refractive Surgery View all 11 articles

12/31/2024

Today (December 31, 2024), we are very excited to receive the very last good news of the year and to announce another publication of the 8th peer-reviewed technical paper on our Asqelio™ Monofocal IOL in the Journal of Ophthalmology (2024, Article ID 3520219). The paper is now available as open access via the link below.

This study aims to analyze the prevalence and severity of posterior capsule opacification (PCO) and glistening in a new hydrophobic bi-aspheric monofocal intraocular lens (IOLs) 24 months after implantation.

The study concluded that prevalence of PCO was considerably lower for Asqelio IOL than for the Control IOL and reports available in the literature for other hydrophobic IOLs. Prevalence of glistening was minimal in both study and control IOLs.

Many thanks to all team members, doctors, the hospital that had contributed and collaborated on this study. The result certainly has further convinced and encouraged us to progressively move forward and to ‘Making Happy Patients, One-by-One'.

https://doi.org/10.1155/joph/3520219
https://onlinelibrary.wiley.com/doi/10.1155/joph/3520219

12/20/2024

We hope this greeting brings a smile to your face and reminds you how much we value one by one.

Wishing you and your loved ones a wonderful holiday season and a prosperous New Year.

 

 

Warmest Regards,

AST VisionCare Group

December 20, 2024

12/20/2024

We hope this greeting brings a smile to your face and reminds you how much we value one by one.

Wishing you and your loved ones a wonderful holiday season and a prosperous New Year.


Warmest Regards,
AST VisionCare Group
December 20, 2024

11/28/2024

Wishing you all a harvest of blessings, good health and good times. Happy Thanksgiving!

10/21/2024

Final day of our exhibition at the 2024 AAO (American Academy of Ophthalmology) Annual Meeting from October 19 to 21, 2024.

Venue: McCormick Place, Chicago.
Please visit us at booth #2129.